Results - Announcements
Gujarat Kidney & Super Speciality Ltd share price slipped 0.56% to Rs 159.75. The Company's net profit surged by 24.06% to Rs 6.6 crore, while revenue from operations increased 11.08% to Rs 38.09 crore in Q3FY26 over Q2FY26.
The market capitalization of Hospital industry group stocks on BSE stood at Rs 6.82 lakh crore, gaining 8.80%. It has improved by 6.05% over last one week and dipped slightly by 7.23% in last one month while the market capitalization of Gujarat Kidney & Super Speciality Ltd has softened by 6.88% and 18.86% in the same period respectively.
Profit before tax (PBT) of Gujarat Kidney & Super Speciality Ltd stood at Rs 8.62 crore in Q3 FY26, rallying 113.90% year-on-year, and expanding by 23.85% quarter-on-quarter. EBITDA came in at Rs 10 crore, surging by 91.45% YoY and jumping 25.23% sequentially.
Total expenses inched up 7.46% to Rs 29.39 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 4.75 crore, growing marginally by 9.45% YoY, while employee benefits expense was at Rs 7.77 crore, soaring 46.88% YoY.
For the TTM ended FY26, revenue from operations witnessed a strong growth of 103.80% to Rs 82.01 crore, while net profit jumped 76.95% to Rs 16.81 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 1681% to Rs 26.07 crore, and PBT soared 66.25% to Rs 21.23 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 3.86 crore in FY26, as against Rs 13.61 crore in FY25.
Gujarat Kidney & Super Speciality Ltd soared by 52.65% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 7.38% during the same period.